Literature DB >> 2828238

Adherence of Streptococcus agalactiae to synchronously growing human cell monolayers without lipoteichoic acid involvement.

S Miyazaki1, O Leon, C Panos.   

Abstract

Freshly isolated virulent and nonvirulent strains of Streptococcus agalactiae type III were used to study differences in coccal adherence to synchronously dividing, subconfluent human embryonic amnion and fetal lung monolayers in vitro. The adherence frequency by virulent isolates of mid-logarithmically growing cocci to amnion cells varied markedly with host cell age, being highest shortly after eucaryotic cell division. This variation was not observed with lung cell monolayers, suggesting that cyclic production or exposure of coccal receptor sites on the eucaryotic cell surface with age is not a common property of all primary human cells in vitro. However, and regardless of age, not all cells within these synchronously dividing populations bound virulent cocci, indicating that a very small segment of a population may always be unresponsive to host cell interactions with a coccal pathogen. By comparison, adherence of nonvirulent coccal isolates to amnion and lung cells remained constant and of a very low order, regardless of host cell age. Maximal adherence of virulent S. agalactiae to young host cells occurred at early and mid-logarithmic phases of growth. However, at the late stationary growth phase, adherence was reduced to almost that of nonvirulent isolates. Pretreatment of virulent S. agalactiae with anti-lipoteichoic acid (LTA) serum failed to inhibit coccal adherence to these different host cells. Heat negated adherence. Group B coccal LTA was cytotoxic for these host cells. However, pretreatment of amnion and lung cells with nontoxic levels of this amphiphile did not prevent attachment of virulent cocci. Finally, coccal pretreatment with pronase abrogated adherence to either host cell even though surface-exposed LTA was uneffected, as observed by the indirect fluorescent-antibody procedure. Likewise, no observable difference in surface LTA was detected when fresh isolates of virulent and nonvirulent coccal strains were compared by this procedure. These studies suggest that protein involvement, rather than LTA, is primarily responsible for mediating virulent S. agalactiae type III attachment to these synchronously growing, subconfluent eucaryotic monolayers in vitro.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2828238      PMCID: PMC259311          DOI: 10.1128/iai.56.2.505-512.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Properties of mitotic cells prepared by mechanically shaking monolayer cultures of Chinese hamster cells.

Authors:  R A Tobey; E C Anderson; D F Petersen
Journal:  J Cell Physiol       Date:  1967-08       Impact factor: 6.384

2.  The adhesion of human and bovine isolates of Streptococcus agalactiae (group B) to bovine mammary gland epithelial cells.

Authors:  A J Bramley; E M Hogben
Journal:  J Comp Pathol       Date:  1982-01       Impact factor: 1.311

3.  Factors influencing adherence of group B streptococci to human vaginal epithelial cells.

Authors:  S M Zawaneh; E M Ayoub; H Baer; A C Cruz; W N Spellacy
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

4.  An electron microscope study of kidney basement membrane changes in the mouse by lipoteichoic acid from Streptococcus pyogenes.

Authors:  O Leon; C Panos
Journal:  Can J Microbiol       Date:  1987-08       Impact factor: 2.419

5.  Group B streptococcal colonization patterns in mothers and their infants.

Authors:  D E Jones; K S Kanarek; D V Lim
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

6.  Group B streptococcal infection: a review and update.

Authors:  J M Knox
Journal:  Br J Vener Dis       Date:  1979-04

7.  Effect of L-form Streptococcus pyogenes and of lipoteichoic acid on human cells in tissue culture.

Authors:  J DeVuono; C Panos
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

8.  Teichoic acids of Streptococcus agalactiae: chemistry, cytotoxicity, and effect on bacterial adherence to human cells in tissue culture.

Authors:  J C Goldschmidt; C Panos
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

9.  Role of cellular lipoteichoic acids in mediating adherence of serotype III strains of group B streptococci to human embryonic, fetal, and adult epithelial cells.

Authors:  T J Nealon; S J Mattingly
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

Review 10.  Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface.

Authors:  E H Beachey
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

View more
  5 in total

1.  Streptococcus pyogenes clinical isolates and lipoteichoic acid.

Authors:  O Leon; C Panos
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  Adherence of group B streptococci to cultured epithelial cells: roles of environmental factors and bacterial surface components.

Authors:  G S Tamura; J M Kuypers; S Smith; H Raff; C E Rubens
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

3.  The fibrinogen receptor FbsA promotes adherence of Streptococcus agalactiae to human epithelial cells.

Authors:  Axel Schubert; Katherina Zakikhany; Giampiero Pietrocola; Andreas Meinke; Pietro Speziale; Bernhard J Eikmanns; Dieter J Reinscheid
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

4.  Cell growth rate regulates expression of group B Streptococcus type III capsular polysaccharide.

Authors:  L C Paoletti; R A Ross; K D Johnson
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

5.  Sialic acid levels and lag time of growth in chemically defined medium containing 200 mM phosphate among strains of various serotypes of Streptococcus agalactiae.

Authors:  Y Nagano; N Nagano; S Takahashi; A Suzuki; Y Okuwaki
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.